Merck & Co | MRK - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Merck & Co

Merck & Co reported $1.79B in Ordinary Share Capital for its fiscal quarter ending in December of 2022.


Ordinary Share Capital Change
Abbott ABT:US USD 24.49B 221M
ALKERMES ALKS:US USD 1.72M 25K
AstraZeneca AZN:LN USD 387M 0
Catalent CTLT:US USD 2M 0
Coherus Biosciences CHRS:US USD 8K 0
Drreddys Laboratories RDY:US INR 833M 0
Eli Lilly LLY:US USD 593.5M 600K
Endo International ENDP:US USD 67K 0
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Glaxosmithkline GSK:US GBP 1.35B 1000K
Horizon Pharma HZNP:US USD 23K 0
Intercept Pharmaceuticals ICPT:US USD 42K 0
J&J JNJ:US USD 3.12B 0
Novartis NOVN:VX USD 842M 48M
Novartis NVS:US USD 842M 48M
Pacira PCRX:US USD 46K 0
Perrigo PRGO:US USD 6.91B 25.9M
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 548K 0
Revance Therapeutics RVNC:US USD 84K 2K
Roche Holding ROG:VX CHF 107M 0
United Therapeutics UTHR:US USD 700K 0
Zoetis ZTS:US USD 5M 0